{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-142932","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2026-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.133971+00:00","generated_at":"2026-05-15T07:15:11.195631+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ImmunityBio submits response to FDA OPDP Warning Letter; outlines corrective actions","bullets":["Submitted comprehensive response to FDA OPDP Warning Letter dated March 13, 2026.","Identified podcast removed from corporate website; requested removal from third-party platforms.","TV advertisement cited in FDA letter was never broadcast or disseminated to the public.","Implementing enhanced compliance: executive training, expanded PRC protocols, external regulatory counsel.","CEO Richard Adcock reaffirms commitment to accurate and compliant promotional communications."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-142932","json":"https://secwatch.observer/filing/0001193125-26-142932.json","markdown":"https://secwatch.observer/filing/0001193125-26-142932.md","text":"https://secwatch.observer/filing/0001193125-26-142932.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000119312526142932/0001193125-26-142932-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000119312526142932/d70606d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:15:11.195631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}